3 Undervalued Biotechs Worth Adding to Your Watch List

3 Undervalued Biotechs Worth Adding to Your Watch List
Alex Carchidi, The Motley Fool
·5 min read

If you're like me, your investment watch list is overflowing with dozens of stocks and price alerts. Let's examine three biotechs trading at lower than average valuations and consider whether they might be worth putting on your watch list. Supernus Pharmaceuticals (NASDAQ: SUPN) makes drugs that treat disorders of the central nervous system, including epilepsy and Parkinson's disease.